{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T20:03:13Z","timestamp":1770408193295,"version":"3.49.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T00:00:00Z","timestamp":1764460800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ctro.2025.101090","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:30:32Z","timestamp":1764635432000},"page":"101090","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Clinical evidence and reporting standards in reirradiation: Insights from 28 studies at ESTRO 2025, endorsed by the ESTRO reirradiation focus group"],"prefix":"10.1016","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5512-4161","authenticated-orcid":false,"given":"Arnaud","family":"Beddok","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ane L.","family":"Appelt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Corradini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aileen","family":"Duffton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4678-0116","authenticated-orcid":false,"given":"Gian Marco","family":"Petrianni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart\u0142omiej","family":"Tomasik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliana","family":"V\u00e1squez Osorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"Willmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolaus","family":"Andratschke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2025.101090_b0005","article-title":"Reirradiation: standards, challenges, and patient-focused strategies across tumor types","author":"Beddok","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ctro.2025.101090_b0010","doi-asserted-by":"crossref","first-page":"e469","DOI":"10.1016\/S1470-2045(22)00447-8","article-title":"European society for radiotherapy and oncology and European organisation for research and treatment of cancer consensus on re-irradiation: definition, reporting, and clinical decision making","volume":"23","author":"Andratschke","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctro.2025.101090_b0015","doi-asserted-by":"crossref","first-page":"S686","DOI":"10.1016\/S0167-8140(25)00768-6","article-title":"1974 Outcomes of reirradiation for recurrent high-grade gliomas: a retrospective analysis of dose and timing effects on survival","volume":"206","author":"Estrella-M\u00e1rquez","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.101090_b0020","doi-asserted-by":"crossref","first-page":"S744","DOI":"10.1016\/S0167-8140(25)03244-X","article-title":"4243 Re-irradiation after Re-surgery in recurrent glioblastoma: a viable strategy? evaluating its role in improving survival outcomes","volume":"206","author":"Martino","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.101090_b0025","doi-asserted-by":"crossref","first-page":"S760","DOI":"10.1016\/S0167-8140(25)03318-3","article-title":"4346 Repeat chemoradiation vs. Re-irradiation alone in recurrent gliomas","volume":"206","author":"Schro\u00ebn","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.101090_b0030","doi-asserted-by":"crossref","first-page":"S700","DOI":"10.1016\/S0167-8140(25)01027-8","article-title":"2401 Oncological outcome of re-irradiation for recurrent glioblastoma \u2013 results of a prospective multicenter trial (GLIAA, NCT01252459)","volume":"206","author":"Popp","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.101090_b0035","doi-asserted-by":"crossref","first-page":"S935","DOI":"10.1016\/S0167-8140(25)03463-2","article-title":"457 Curative proton reirradiation (re-PT) in recurrent head and neck cancers (HNC): outcomes and toxicities","volume":"206","author":"Suwichanarakul","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.101090_b0040","doi-asserted-by":"crossref","first-page":"S1551","DOI":"10.1016\/S0167-8140(25)01550-6","article-title":"3204 Real-world reirradiation treatment and disease characteristics: interim analysis of the prospective observational E2-RADIatE ReCare cohort","volume":"206","author":"Willmann","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.101090_b0045","doi-asserted-by":"crossref","first-page":"S1361","DOI":"10.1016\/S0167-8140(25)01142-9","article-title":"2563 Is curatively intended reirradiation in lung cancer patients feasible? a retrospective study with clinical and dosimetric data","volume":"206","author":"Knap","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.101090_b0050","doi-asserted-by":"crossref","first-page":"S1434","DOI":"10.1016\/S0167-8140(25)03264-5","article-title":"4269 High dose reirradiation for intrathoracic relapse of lung cancer: a retrospective experience","volume":"206","author":"Cammareri","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.101090_b0055","doi-asserted-by":"crossref","first-page":"S1355","DOI":"10.1016\/S0167-8140(25)01077-1","article-title":"2469 Reirradiation for lung cancer: investigating toxicity and outcomes","volume":"206","author":"Lacoste","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.101090_b0060","doi-asserted-by":"crossref","first-page":"S1582","DOI":"10.1016\/S0167-8140(25)03220-7","article-title":"4213 Four years\u2019 experience of thoracic re-irradiation in a single centre","volume":"206","author":"Sunyach","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.101090_b0065","doi-asserted-by":"crossref","first-page":"S469","DOI":"10.1016\/S0167-8140(25)00298-1","article-title":"1120 Proton beam hypofractionated reirradiation in locoregionally recurrent breast cancer: early toxicity outcomes","volume":"206","author":"Dicuonzo","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.101090_b0070","doi-asserted-by":"crossref","first-page":"S583","DOI":"10.1016\/S0167-8140(25)01789-X","article-title":"3548 Efficacy and toxicity of re-irradiation for breast cancer patients with locoregional recurrence: a retrospective analysis","volume":"206","author":"Zhang","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.101090_b0075","doi-asserted-by":"crossref","first-page":"S1833","DOI":"10.1016\/S0167-8140(25)01755-4","article-title":"3493 Re-irradiation in recurrent esophageal cancer: toxicity and survival","volume":"206","author":"Mattioli","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.101090_b0080","doi-asserted-by":"crossref","first-page":"S1280","DOI":"10.1016\/S0167-8140(25)03286-4","article-title":"4297 Chemotherapy and reirradiation vs chemotherapy as preoperative treatment for recurrent rectal cancer: the GRECCAR15 randomized trial (NCT03879109)","volume":"206","author":"Vendrely","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.101090_b0085","doi-asserted-by":"crossref","first-page":"S1463","DOI":"10.1016\/S0167-8140(25)04229-X","article-title":"542 FINAL RESULTS FROM a PHASE I DOSE ESCALATION STUDY (DESTROY-1) IN STEREOTACTIC REIRRADIATION","volume":"206","author":"Deodato","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.101090_b0090","doi-asserted-by":"crossref","first-page":"S1726","DOI":"10.1016\/S0167-8140(25)03155-X","article-title":"4123 High-dose carbon ion reirradiation for recurrent sacral chordoma","volume":"206","author":"Chalaszczyk","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.101090_b0095","doi-asserted-by":"crossref","first-page":"S1914","DOI":"10.1016\/S0167-8140(25)00249-X","article-title":"1021 RE-START: a national registry including patients undergoing reirradiation after previous RT for prostate cancer. a study on behalf of AIRO","volume":"206","author":"Francolini","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.101090_b0100","doi-asserted-by":"crossref","first-page":"S1953","DOI":"10.1016\/S0167-8140(25)00541-9","article-title":"1578 Pushing the boundaries of SBRT in irradiated territories for nodal oligorecurrent prostate cancer: outcomes of the CYGNUS retrospective study","volume":"206","author":"Anger","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.101090_b0105","doi-asserted-by":"crossref","first-page":"S1996","DOI":"10.1016\/S0167-8140(25)00991-0","article-title":"2347 Prostate reirradiation with online daily-adaptive stereotactic body radiotherapy (SBRT) on 1.5T MR-linac","volume":"206","author":"Nicosia","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.101090_b0110","doi-asserted-by":"crossref","first-page":"S2038","DOI":"10.1016\/S0167-8140(25)01517-8","article-title":"3143 follow-up of an \u201cEMBARK-like\u201d cohort of prostate cancer patients using molecular imaging: a single-center","volume":"206","author":"Cerrolaza","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.101090_b0115","doi-asserted-by":"crossref","first-page":"S2081","DOI":"10.1016\/S0167-8140(25)03031-2","article-title":"3943 Hypofractionated reirradiation with proton therapy for prostate cancer local recurrence: early toxicity assessment","volume":"206","author":"Mastroleo","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.101090_b0120","doi-asserted-by":"crossref","first-page":"S2115","DOI":"10.1016\/S0167-8140(25)03275-X","article-title":"4286 PSMA-targeted focal stereotactic Re-irradiation in two fractions for recurrent prostate cancer post- definitive radiation therapy","volume":"206","author":"Hammer","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.101090_b0125","doi-asserted-by":"crossref","first-page":"S703","DOI":"10.1016\/S0167-8140(25)01140-5","article-title":"2560 EFFICACY AND SAFETY OF a SECOND COURSE OF WHOLE-BRAIN RADIOTHERAPY FOR MULTIPLE BRAIN METASTASES: KEY DETERMINANTS FOR PATIENT SELECTION","volume":"206","author":"Nicolau","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.101090_b0130","doi-asserted-by":"crossref","first-page":"S1579","DOI":"10.1016\/S0167-8140(25)03209-8","article-title":"4201 Reirradiation of bone metastases: satisfactory local control with low toxicity in a large retrospective series","volume":"206","author":"Repetti","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.101090_b0135","doi-asserted-by":"crossref","first-page":"S1778","DOI":"10.1016\/S0167-8140(25)00647-4","article-title":"1780 Clinical and dosimetric outcomes of stereotactic MR-guided adaptive radiotherapy (SMART) reirradiation for liver metastases","volume":"206","author":"Moreno-Olmedo","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.101090_b0140","doi-asserted-by":"crossref","first-page":"S1613","DOI":"10.1016\/S0167-8140(25)04223-9","article-title":"533 Reirradiation for recurrent diffuse intrinsic pontine glioma and diffuse midline glioma is associated with improved survival","volume":"206","author":"Shariff","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.101090_b0145","doi-asserted-by":"crossref","first-page":"S1628","DOI":"10.1016\/S0167-8140(25)00872-2","article-title":"2138 Diffuse intrinsic pontine glioma: is reirradiation the only option for improved outcomes?","volume":"206","author":"Jim\u00e9nez","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.101090_b0150","doi-asserted-by":"crossref","first-page":"S1626","DOI":"10.1016\/S0167-8140(25)00807-2","article-title":"2038 Re-irradiation for recurrent pediatric CNS tumors: insights into survival, toxicity, and symptom control","volume":"206","author":"Estrella-M\u00e1rquez","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.101090_b0155","doi-asserted-by":"crossref","unstructured":"Paradis KC, Mayo C, Matrosic CK, Prisciandaro JI, Rosen BS, Allen SG, et al. Reirradiation Special Medical Physics Consultations: Lessons Learned from Nearly 3000 Courses of Treatment. Int J Radiat Oncol Biol Phys 2025:S0360-3016(25)00233-0. https:\/\/doi.org\/10.1016\/j.ijrobp.2025.03.002.","DOI":"10.1016\/j.ijrobp.2025.03.002"},{"key":"10.1016\/j.ctro.2025.101090_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109947","article-title":"Re-irradiation in clinical practice: results of an international patterns of care survey within the framework of the ESTRO-EORTC E2-RADIatE platform","volume":"189","author":"Willmann","year":"2023","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"10.1016\/j.ctro.2025.101090_b0165","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ijrobp.2024.04.001","article-title":"Incorporation of functional lung imaging into radiation therapy planning in patients with lung cancer: a systematic review and meta-analysis","volume":"120","author":"Midroni","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2025.101090_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109585","article-title":"Challenges of re-irradiation: a call to arms for physicists - and radiotherapy vendors","volume":"182","author":"Vasquez Osorio","year":"2023","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"10.1016\/j.ctro.2025.101090_b0175","article-title":"A standardised workflow to manage the complexity of reirradiation and radiotherapy retreatments in clinical practice","volume":"35","author":"Day","year":"2025","journal-title":"Tech Innov Patient Support Radiat Oncol"},{"key":"10.1016\/j.ctro.2025.101090_b0180","article-title":"Ongoing prospective studies on reirradiation: a systematic review of a clinical trials database","author":"Willmann","year":"2024","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"10.1016\/j.ctro.2025.101090_b0185","doi-asserted-by":"crossref","unstructured":"Mayo CS, Appelt AL, Paradis KC, Dawson LA, Andratschke N, Vasquez Osorio EM, et al. Joining Forces to Advance Reirradiation: Establishing the Reirradiation Collaborative Group. Int J Radiat Oncol Biol Phys 2025:S0360-3016(25)00139-7. https:\/\/doi.org\/10.1016\/j.ijrobp.2025.01.038.","DOI":"10.1016\/j.ijrobp.2025.01.038"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240563082500182X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240563082500182X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T12:22:25Z","timestamp":1770034945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240563082500182X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":37,"alternative-id":["S240563082500182X"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2025.101090","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical evidence and reporting standards in reirradiation: Insights from 28 studies at ESTRO 2025, endorsed by the ESTRO reirradiation focus group","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2025.101090","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101090"}}